Jacobs Levy Equity Management Inc. Sells 4,146 Shares of Inari Medical, Inc. (NASDAQ:NARI)

Jacobs Levy Equity Management Inc. lowered its position in Inari Medical, Inc. (NASDAQ:NARI) by 3.4% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 118,576 shares of the company’s stock after selling 4,146 shares during the quarter. Jacobs Levy Equity Management Inc. owned approximately 0.20% of Inari Medical worth $6,053,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of NARI. Smartleaf Asset Management LLC grew its stake in Inari Medical by 128.1% in the fourth quarter. Smartleaf Asset Management LLC now owns 634 shares of the company’s stock worth $33,000 after purchasing an additional 356 shares in the last quarter. R Squared Ltd bought a new position in Inari Medical in the fourth quarter worth approximately $45,000. Quarry LP bought a new position in Inari Medical in the fourth quarter worth approximately $57,000. Quadrant Capital Group LLC grew its stake in Inari Medical by 12.3% in the fourth quarter. Quadrant Capital Group LLC now owns 1,301 shares of the company’s stock worth $66,000 after purchasing an additional 143 shares in the last quarter. Finally, KBC Group NV grew its stake in Inari Medical by 31.5% in the fourth quarter. KBC Group NV now owns 2,333 shares of the company’s stock worth $119,000 after purchasing an additional 559 shares in the last quarter. Institutional investors own 90.98% of the company’s stock.

Inari Medical Stock Performance

Shares of NASDAQ NARI opened at $79.97 on Wednesday. The stock has a market capitalization of $4.68 billion, a PE ratio of -59.24 and a beta of 1.02. The stock’s fifty day simple moving average is $79.97 and its two-hundred day simple moving average is $70.01. Inari Medical, Inc. has a 12-month low of $39.76 and a 12-month high of $79.99.

About Inari Medical

Inari Medical, Inc builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.